These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 26019226)

  • 1. Allogeneic Neural Stem/Progenitor Cells Derived From Embryonic Stem Cells Promote Functional Recovery After Transplantation Into Injured Spinal Cord of Nonhuman Primates.
    Iwai H; Shimada H; Nishimura S; Kobayashi Y; Itakura G; Hori K; Hikishima K; Ebise H; Negishi N; Shibata S; Habu S; Toyama Y; Nakamura M; Okano H
    Stem Cells Transl Med; 2015 Jul; 4(7):708-19. PubMed ID: 26019226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of remyelination by neural stem/progenitor cells transplanted into the injured spinal cord.
    Yasuda A; Tsuji O; Shibata S; Nori S; Takano M; Kobayashi Y; Takahashi Y; Fujiyoshi K; Hara CM; Miyawaki A; Okano HJ; Toyama Y; Nakamura M; Okano H
    Stem Cells; 2011 Dec; 29(12):1983-94. PubMed ID: 22028197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transplantation of galectin-1-expressing human neural stem cells into the injured spinal cord of adult common marmosets.
    Yamane J; Nakamura M; Iwanami A; Sakaguchi M; Katoh H; Yamada M; Momoshima S; Miyao S; Ishii K; Tamaoki N; Nomura T; Okano HJ; Kanemura Y; Toyama Y; Okano H
    J Neurosci Res; 2010 May; 88(7):1394-405. PubMed ID: 20091712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-evaluated safe human iPSC-derived neural stem cells promote functional recovery after spinal cord injury in common marmoset without tumorigenicity.
    Kobayashi Y; Okada Y; Itakura G; Iwai H; Nishimura S; Yasuda A; Nori S; Hikishima K; Konomi T; Fujiyoshi K; Tsuji O; Toyama Y; Yamanaka S; Nakamura M; Okano H
    PLoS One; 2012; 7(12):e52787. PubMed ID: 23300777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transplantation of neural stem/progenitor cells at different locations in mice with spinal cord injury.
    Iwai H; Nori S; Nishimura S; Yasuda A; Takano M; Tsuji O; Fujiyoshi K; Toyama Y; Okano H; Nakamura M
    Cell Transplant; 2014; 23(11):1451-64. PubMed ID: 23998989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient derivation of multipotent neural stem/progenitor cells from non-human primate embryonic stem cells.
    Shimada H; Okada Y; Ibata K; Ebise H; Ota S; Tomioka I; Nomura T; Maeda T; Kohda K; Yuzaki M; Sasaki E; Nakamura M; Okano H
    PLoS One; 2012; 7(11):e49469. PubMed ID: 23166679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polarized Macrophages Have Distinct Roles in the Differentiation and Migration of Embryonic Spinal-cord-derived Neural Stem Cells After Grafting to Injured Sites of Spinal Cord.
    Zhang K; Zheng J; Bian G; Liu L; Xue Q; Liu F; Yu C; Zhang H; Song B; Chung SK; Ju G; Wang J
    Mol Ther; 2015 Jun; 23(6):1077-1091. PubMed ID: 25794051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neural stem/progenitor cell-laden microfibers promote transplant survival in a mouse transected spinal cord injury model.
    Sugai K; Nishimura S; Kato-Negishi M; Onoe H; Iwanaga S; Toyama Y; Matsumoto M; Takeuchi S; Okano H; Nakamura M
    J Neurosci Res; 2015 Dec; 93(12):1826-38. PubMed ID: 26301451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Grafted Human iPS Cell-Derived Oligodendrocyte Precursor Cells Contribute to Robust Remyelination of Demyelinated Axons after Spinal Cord Injury.
    Kawabata S; Takano M; Numasawa-Kuroiwa Y; Itakura G; Kobayashi Y; Nishiyama Y; Sugai K; Nishimura S; Iwai H; Isoda M; Shibata S; Kohyama J; Iwanami A; Toyama Y; Matsumoto M; Nakamura M; Okano H
    Stem Cell Reports; 2016 Jan; 6(1):1-8. PubMed ID: 26724902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rehabilitative Training Enhances Therapeutic Effect of Human-iPSC-Derived Neural Stem/Progenitor Cells Transplantation in Chronic Spinal Cord Injury.
    Shibata T; Tashiro S; Shibata S; Shinozaki M; Shindo T; Hashimoto S; Kawai M; Kitagawa T; Ago K; Matsumoto M; Nakamura M; Okano H; Nagoshi N
    Stem Cells Transl Med; 2023 Mar; 12(2):83-96. PubMed ID: 36647673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A robust culture system to generate neural progenitors with gliogenic competence from clinically relevant induced pluripotent stem cells for treatment of spinal cord injury.
    Kamata Y; Isoda M; Sanosaka T; Shibata R; Ito S; Okubo T; Shinozaki M; Inoue M; Koya I; Shibata S; Shindo T; Matsumoto M; Nakamura M; Okano H; Nagoshi N; Kohyama J
    Stem Cells Transl Med; 2021 Mar; 10(3):398-413. PubMed ID: 33226180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time-dependent changes in the microenvironment of injured spinal cord affects the therapeutic potential of neural stem cell transplantation for spinal cord injury.
    Nishimura S; Yasuda A; Iwai H; Takano M; Kobayashi Y; Nori S; Tsuji O; Fujiyoshi K; Ebise H; Toyama Y; Okano H; Nakamura M
    Mol Brain; 2013 Jan; 6():3. PubMed ID: 23298657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo monitoring of remnant undifferentiated neural cells following human induced pluripotent stem cell-derived neural stem/progenitor cells transplantation.
    Tanimoto Y; Yamasaki T; Nagoshi N; Nishiyama Y; Nori S; Nishimura S; Iida T; Ozaki M; Tsuji O; Ji B; Aoki I; Jinzaki M; Matsumoto M; Fujibayashi Y; Zhang MR; Nakamura M; Okano H
    Stem Cells Transl Med; 2020 Apr; 9(4):465-477. PubMed ID: 31904914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocyte growth factor pretreatment boosts functional recovery after spinal cord injury through human iPSC-derived neural stem/progenitor cell transplantation.
    Suematsu Y; Nagoshi N; Shinozaki M; Kase Y; Saijo Y; Hashimoto S; Shibata T; Kajikawa K; Kamata Y; Ozaki M; Yasutake K; Shindo T; Shibata S; Matsumoto M; Nakamura M; Okano H
    Inflamm Regen; 2023 Oct; 43(1):50. PubMed ID: 37845736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlling immune rejection is a fail-safe system against potential tumorigenicity after human iPSC-derived neural stem cell transplantation.
    Itakura G; Kobayashi Y; Nishimura S; Iwai H; Takano M; Iwanami A; Toyama Y; Okano H; Nakamura M
    PLoS One; 2015; 10(2):e0116413. PubMed ID: 25706286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Administration of C5a Receptor Antagonist Improves the Efficacy of Human Induced Pluripotent Stem Cell-Derived Neural Stem/Progenitor Cell Transplantation in the Acute Phase of Spinal Cord Injury.
    Shibata R; Nagoshi N; Kajikawa K; Ito S; Shibata S; Shindo T; Khazaei M; Nori S; Kohyama J; Fehlings MG; Matsumoto M; Nakamura M; Okano H
    J Neurotrauma; 2022 May; 39(9-10):667-682. PubMed ID: 35196890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell Transplantation for Spinal Cord Injury: Tumorigenicity of Induced Pluripotent Stem Cell-Derived Neural Stem/Progenitor Cells.
    Deng J; Zhang Y; Xie Y; Zhang L; Tang P
    Stem Cells Int; 2018; 2018():5653787. PubMed ID: 29535771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of ES cell-derived gliogenic neural stem/progenitor cells in functional recovery after spinal cord injury.
    Kumagai G; Okada Y; Yamane J; Nagoshi N; Kitamura K; Mukaino M; Tsuji O; Fujiyoshi K; Katoh H; Okada S; Shibata S; Matsuzaki Y; Toh S; Toyama Y; Nakamura M; Okano H
    PLoS One; 2009 Nov; 4(11):e7706. PubMed ID: 19893739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional recovery in traumatic spinal cord injury after transplantation of multineurotrophin-expressing glial-restricted precursor cells.
    Cao Q; Xu XM; Devries WH; Enzmann GU; Ping P; Tsoulfas P; Wood PM; Bunge MB; Whittemore SR
    J Neurosci; 2005 Jul; 25(30):6947-57. PubMed ID: 16049170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transplantation of Induced Pluripotent Stem Cell-Derived Neural Stem Cells Mediate Functional Recovery Following Thoracic Spinal Cord Injury Through Remyelination of Axons.
    Salewski RP; Mitchell RA; Li L; Shen C; Milekovskaia M; Nagy A; Fehlings MG
    Stem Cells Transl Med; 2015 Jul; 4(7):743-54. PubMed ID: 25979861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.